NCT06537167Not yet recruiting
Transcutaneous Electrical Acupoint Stimulation on Blood Pressure
The Antihypertensive Effects of Transcutaneous Electrical Acupoint Stimulation in Patients With High-normal Blood Pressure and Grade 1 Hypertension
Source: ClinicalTrials.gov · Last updated 15 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study will be conducted in patients with high-normal blood pressure and grade 1 hypertension and will be divided into two phases. In Phase One, a small group of patients will undergo transcutaneous electrical acupoint stimulation treatment for three consecutive days. Blood pressure changes will be observed before and after each stimulation session, as well as 1 hour, 3 hours, and 5 hours after stimulation, during the night of the treatment day, and the next morning. Phase Two will be a single-center, single-blind, parallel randomized controlled trial. After screening, patients will be randomly assigned to either the "stimulation" experimental group or the "sham stimulation" control group. For three consecutive days, both groups will receive their respective interventions at the same time each day, and their blood pressure changes will be recorded.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 31 Jul 2024
- Start date
- Aug 2025
- Primary completion date
- Dec 2027
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
- Diseases
- High blood pressure
- NCT number
- NCT06537167
What you commit to
- Study type: Interventional
- Planned participants: 120
- From Aug 2025 to the primary completion date, Dec 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe heart conditions, including coronary heart disease, myocardial infarction, arrhythmia, heart failure, or having an implanted cardiac pacemaker
- Skin conditions, including eczema, allergic dermatitis, or seborrheic dermatitis
- Neuromuscular diseases, mental disorders, epilepsy, or cognitive impairment
- Lower limb deep vein thrombosis or thrombophlebitis
- Wounds, surgical scars, or malignant tumors at the stimulation areas
- Inability to tolerate the transcutaneous electrical acupoint stimulation treatment or allergic to electrical stimulation
Other
- Pregnant or breastfeeding women
- Currently participating in other clinical trials
Who the study is looking for
- Office systolic blood pressure between 130-150 mmHg and/or diastolic blood pressure between 80-95 mmHg
- Age between 18 and 75 years
- Not currently receiving antihypertensive medication or having discontinued antihypertensive medication for more than two weeks
- Able to undergo and complete the transcutaneous electrical acupoint stimulation treatment
- Agree to participate and sign the informed consent form
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.